Literature DB >> 23462967

'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach.

Che-Ming J Hu1, Ronnie H Fang, Brian T Luk, Kevin N H Chen, Cody Carpenter, Weiwei Gao, Kang Zhang, Liangfang Zhang.   

Abstract

We investigate the 'marker-of-self' functionalization of nanoparticles through coating of natural RBC membranes. The membrane translocation approach is shown to be highly efficient and bestows nanoparticles with correctly oriented and functional immunomodulatory proteins such as CD47 at equivalent density to natural RBCs.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23462967      PMCID： PMC3667603          DOI： 10.1039/c3nr00015j

Source DB:  PubMed          Journal:  Nanoscale        ISSN： 2040-3364            Impact factor:   7.790


  19 in total

1.  Comparison of normal blood picture of young adults from 18 inbred strains of mice.

Authors:  E S RUSSELL; E F NEUFELD; C T HIGGINS
Journal:  Proc Soc Exp Biol Med       Date:  1951-12

Review 2.  Integrin-associated protein (CD47) and its ligands.

Authors:  E J Brown; W A Frazier
Journal:  Trends Cell Biol       Date:  2001-03       Impact factor: 20.808

3.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

4.  Mechanical measurement of red cell membrane thickness.

Authors:  R M Hochmuth; C A Evans; H C Wiles; J T McCown
Journal:  Science       Date:  1983-04-01       Impact factor: 47.728

5.  Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)--major differences between mouse and man and implications for signaling.

Authors:  Shyamsundar Subramanian; Richard Tsai; Shamik Sen; Kris Noel Dahl; Dennis E Discher
Journal:  Blood Cells Mol Dis       Date:  2006-05-11       Impact factor: 3.039

6.  Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo.

Authors:  C M Cameron; J W Barrett; M Mann; A Lucas; Grant McFadden
Journal:  Virology       Date:  2005-06-20       Impact factor: 3.616

7.  Role of sialic acid in erythrocyte survival.

Authors:  J R Durocher; R C Payne; M E Conrad
Journal:  Blood       Date:  1975-01       Impact factor: 22.113

8.  Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47.

Authors:  Isabelle Mouro-Chanteloup; Jean Delaunay; Pierre Gane; Virginie Nicolas; Mette Johansen; Eric J Brown; Luanne L Peters; Caroline Le Van Kim; Jean Pierre Cartron; Yves Colin
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

9.  Reduced phagocytosis of colloidal carriers using soluble CD47.

Authors:  Yu-Chih Hsu; Marcela Acuña; Stanley M Tahara; Ching-An Peng
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

10.  Role of surface electric charge in red blood cell interactions.

Authors:  K M Jan; S Chien
Journal:  J Gen Physiol       Date:  1973-05       Impact factor: 4.086
View more
  75 in total

1.  Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation.

Authors:  Fangda Xu; Michael Reiser; Xinwei Yu; Suryaram Gummuluru; Lee Wetzler; Björn M Reinhard
Journal:  ACS Nano       Date:  2016-01-06       Impact factor: 15.881

2.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

4.  Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.

Authors:  Diana Dehaini; Xiaoli Wei; Ronnie H Fang; Sarah Masson; Pavimol Angsantikul; Brian T Luk; Yue Zhang; Man Ying; Yao Jiang; Ashley V Kroll; Weiwei Gao; Liangfang Zhang
Journal:  Adv Mater       Date:  2017-02-15       Impact factor: 30.849

5.  Synthesis of Nanogels via Cell Membrane-Templated Polymerization.

Authors:  Jianhua Zhang; Weiwei Gao; Ronnie H Fang; Anjie Dong; Liangfang Zhang
Journal:  Small       Date:  2015-06-05       Impact factor: 13.281

6.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

7.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

Review 8.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

9.  Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.

Authors:  Alexander S Cheung; Sandeep T Koshy; Alexander G Stafford; Maartje M C Bastings; David J Mooney
Journal:  Small       Date:  2016-03-08       Impact factor: 13.281

10.  Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles.

Authors:  Brian T Luk; Che-Ming Jack Hu; Ronnie H Fang; Diana Dehaini; Cody Carpenter; Weiwei Gao; Liangfang Zhang
Journal:  Nanoscale       Date:  2014-01-27       Impact factor: 7.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.